Literature DB >> 19186135

Functional and structural characterization of factor Xa dimer in solution.

Rima Chattopadhyay1, Roxana Iacob, Shalmali Sen, Rinku Majumder, Kenneth B Tomer, Barry R Lentz.   

Abstract

Previous studies showed that binding of water-soluble phosphatidylserine (C6PS) to bovine factor Xa (FXa) leads to Ca2+-dependent dimerization in solution. We report the effects of Ca2+, C6PS, and dimerization on the activity and structure of human and bovine FXa. Both human and bovine dimers are 10(6)- to 10(7)-fold less active toward prothrombin than the monomer, with the decrease being attributed mainly to a substantial decrease in k(cat). Dimerization appears not to block the active site, since amidolytic activity toward a synthetic substrate is largely unaffected. Circular dichroism reveals a substantial change in tertiary or quaternary structure with a concomitant decrease in alpha-helix upon dimerization. Mass spectrometry identifies a lysine (K(270)) in the catalytic domain that appears to be buried at the dimer interface and is part of a synthetic peptide sequence reported to interfere with factor Va (FVa) binding. C6PS binding exposes K(351) (part of a reported FVa binding region), K(242) (adjacent to the catalytic triad), and K(420) (part of a substrate exosite). We interpret our results to mean that C6PS-induced dimerization produces substantial conformational changes or domain rearrangements such that structural data on PS-activated FXa is required to understand the structure of the FXa dimer or the FXa-FVa complex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186135      PMCID: PMC2716635          DOI: 10.1016/j.bpj.2008.10.013

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  57 in total

1.  Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.

Authors:  E O Hochleitner; C Borchers; C Parker; R J Bienstock; K B Tomer
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  A trafficking checkpoint controls GABA(B) receptor heterodimerization.

Authors:  M Margeta-Mitrovic; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

3.  Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.

Authors:  A R Rezaie
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

4.  Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum.

Authors:  M T Murakami; J Rios-Steiner; S E Weaver; A Tulinsky; J H Geiger; R K Arni
Journal:  J Mol Biol       Date:  2006-11-14       Impact factor: 5.469

5.  Identification of a binding site for quaternary amines in factor Xa.

Authors:  D Monnaie; D Arosio; N Griffon; T Rose; A R Rezaie; E Di Cera
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

6.  Sequential changes in trace metal, metallothionein and calmodulin concentrations in healing skin wounds.

Authors:  A B Lansdown; B Sampson; A Rowe
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

7.  Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.

Authors:  A R Rezaie; X He
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

8.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.

Authors:  N Sreerama; R W Woody
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

9.  Crystal structures of human factor Xa complexed with potent inhibitors.

Authors:  S Maignan; J P Guilloteau; S Pouzieux; Y M Choi-Sledeski; M R Becker; S I Klein; W R Ewing; H W Pauls; A P Spada; V Mikol
Journal:  J Med Chem       Date:  2000-08-24       Impact factor: 7.446

10.  A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Blood       Date:  2008-06-27       Impact factor: 22.113

View more
  5 in total

1.  Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation.

Authors:  Tilen Koklic; Rinku Majumder; Barry R Lentz
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

2.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

3.  Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.

Authors:  Rinku Majumder; Tilen Koklic; Alireza R Rezaie; Barry R Lentz
Journal:  Biochemistry       Date:  2012-12-27       Impact factor: 3.162

4.  Factor XA binding to phosphatidylserine-containing membranes produces an inactive membrane-bound dimer.

Authors:  Tilen Koklic; Rinku Majumder; Gabriel E Weinreb; Barry R Lentz
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

5.  Soluble phosphatidylserine binds to two sites on human factor IXa in a Ca2+ dependent fashion to specifically regulate structure and activity.

Authors:  Rinku Majumder; Tilen Koklic; Tanusree Sengupta; Daud Cole; Rima Chattopadhyay; Subir Biswas; Dougald Monroe; Barry R Lentz
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.